Skip to main content
OpenTrials
Completed

NCT Number: NCT00451230

Metabolic Effects of Cocaine

The goal of this this study is to elucidate the role of the HPA axis in the pathophysiology of cocaine dependence

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–49 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02116, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals with DSM IV diagnosis of cocaine dependence, medically healthy

Exclusion criteria

  • Other than cocaine dependence DSM-IV axis I diagnosis

Treatment and study plan

Cocaine

Drug

Hydrocortisone

Drug

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • National Alliance for Research on Schizophrenia and Depression

Registry information

Official study title

Elucidating the Role of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Mechanisms Underlying Cocaine Dependence

Important dates

Study start
2005
Primary completion
2005
Study completion
2005
First posted
Mar 23, 2007
Registry last updated
Jan 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.